Varicella-zoster virus causes chickenpox and is a member of the herpes virus group. It is extremely contagious and causes a ...

These two reports address the effects of varicella-zoster vaccination and varicella vaccination. Richard Whitley, who chaired the data and safety monitoring board for the Shingles Prevention Study ...

SEATTLE, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Curevo Vaccine (Curevo), a privately-held clinical-stage biotechnology company dedicated to developing varicella zoster virus (VZV) vaccines with ...

asked Harris. “Preventing shingles through vaccination may, therefore, be one strategy to slow dementia progression in those exhibiting underlying neuropathology of dementia.” The industry-funded ...

GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory ...

Based upon these results, Curevo will advance amezosvatein into global Phase 3 trials in 2025 to address a market for shingles vaccination currently exceeding $4 billion annually. Amezosvatein and ...

Cohen's research is waiting for peer review and publication. There is a vaccine for shingles that's more than 90% effective but only about a quarter of eligible adults get it. "I'm hoping that we ...

Jiangsu Recbio Technology Co., Ltd. Class H (HK:2179) has released an update. Jiangsu Recbio Technology has launched a phase III clinical trial in China for its novel shingles vaccine, REC610 ...

The varicella vaccine is highly effective, making chickenpox less common than it once was. After you get chickenpox, the virus stays in your body and can cause shingles, a painful rash ...

Zero shingles cases after 18.8 months follow-up in 619 patients receiving any dose of amezosvatein, a development-stage adjuvanted subunit ...

Zero shingles cases after 18.8 months follow-up in 619 patients receiving any dose of amezosvatein, a development-stage adjuvanted subunit vaccine -- Ten shingles cases would have been expected ...